middle.news
Resonance Health Surges with $5M Quarterly Receipts and $13.8M Clinical Trial Win
7:03pm on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Resonance Health Surges with $5M Quarterly Receipts and $13.8M Clinical Trial Win
7:03pm on Monday 2nd of June, 2025 AEST
Key Points
Record quarterly customer receipts of $5 million, up 57% from prior quarter
Major clinical trial contract worth $13.8 million announced in November 2024
Positive operating cash flow of $1.1 million for the quarter and $2.5 million over 12 months
TrialsWest acquisition performing strongly with $3.2 million deferred payment made
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Resonance Health (ASX:RHT)
OPEN ARTICLE